Inhibition of AKT signalling by benzoxazine derivative LTUR6 through the modulation of downstream kinases
- 47 Downloads
Many compounds structurally similar to chromones have been developed to enhance the sensitizing effect of cancer cells to chemotherapeutic agents. Most of these compounds have been shown to promote this sensitization by targeting the repair pathways. One such compound is LTUR6, which enhances the sensitization of doxorubicin to colon cancer cells HT29, by inhibiting the phosphorylation of the double stranded break (DSB) repair enzyme AKT. The downstream regulatory targets of AKT that enhance doxorubicin mediated cytotoxicity in the presence of LTUR6 remains elusive. In this study, we performed comparative analyses of 43 kinase phosphorylation sites using the human phospho-kinase array proteome profiler. Results revealed altered expression levels of multiple proteins that regulated apoptotic signalling pathways. Increased activation of mTOR, RSK1/2/3, p38α and PRAS40 after combination treatment with LTUR6 and doxorubicin over doxorubicin alone was observed. This study provides a deeper insight into the key proteins involved and presents a novel molecular pathway.
KeywordsDoxorubicin Apoptosis AKT Chemosensitization
The authors would like to thank Dr. Jasim Al-Rawi and Rick Morrison for supplying LTUR6 compound, which was synthesized in their laboratory. The authors would like to thank Dr. Mike Angove for his constant encouragement and support.
This work was funded by Australian Postgraduate Award and LaTrobe University Postgraduate Research Scholarship (PhD fellowship to Rejitha Suraj).
Compliance with ethical standards
Conflict of interest
All the authors declare that they have no conflict of interest.
This article does not contain any studies with human participants or animals performed by any of the authors.
- 1.Cantley LC (2002) The phosphoinositide 3-kinase pathway. Science 296(5573):1655–1657. https://doi.org/10.1126/science.296.5573.1655
- 2.Fruman DA, Meyers RE, Cantley LC (1998) Phosphoinositide kinases. Annu Rev Biochem. https://doi.org/10.1146/annurev.biochem.67.1.481
- 8.Sarbassov DD, Guertin DA, Ali SM, Sabatini DM (2005) Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex. Science 307(5712):1098–1101. https://doi.org/10.1126/science.1106148
- 9.Morrison R, Al-Rawi JMA (2016) Synthesis, structure elucidation, DNA-PK, PI3K, anti-platelet and anti-bacteria activity of linear 5, 6, and 10-substituted-2-morpholino-chromen-oxazine-dione and angular 3, 4, 6-substituted-8-morpholino-chromen-oxazine-2,10-dione. J Enzyme Inhib Med Chem 31:86–95. https://doi.org/10.1080/14756366.2016.1190710 CrossRefGoogle Scholar
- 13.Neise D, Sohn D, Stefanski A et al (2013) The p90 ribosomal S6 kinase (RSK) inhibitor BI-D1870 prevents gamma irradiation-induced apoptosis and mediates senescence via RSK- and p53-independent accumulation of p21WAF1/CIP1. Cell Death Dis 4:e859. https://doi.org/10.1038/cddis.2013.386 CrossRefGoogle Scholar
- 20.Laplante M, Sabatini DM (2012) mTOR signaling in growth control and disease. Cell 149:274–293. https://doi.org/10.1016/j.cell.2012.03.017
- 22.Zuluaga S, Álvarez-Barrientos A, Gutiérrez-Uzquiza A et al (2007) Negative regulation of Akt activity by p38α MAP kinase in cardiomyocytes involves membrane localization of PP2A through interaction with caveolin-1. Cell Signal. https://doi.org/10.1016/j.cellsig.2006.05.032
- 23.Gratton JP, Morales-Ruiz M, Kureishi Y, Fulton D, Walsh K, Sessa WC (2001) Akt Down-regulation of p38 signaling provides a novel mechanism of vascular endothelial growth factor-mediated cytoprotection in endothelial cells. J Biol Chem 276:30359–30365. https://doi.org/10.1074/jbc.M009698200 CrossRefGoogle Scholar